These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today? Caínzos M. Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462 [Abstract] [Full Text] [Related]
6. [Therapy of SSTI and role of tigecycline]. Concia E. Infez Med; 2009 Sep 01; 17 Suppl 4():64-76. PubMed ID: 20428022 [Abstract] [Full Text] [Related]
7. Daptomycin: rationale and role in the management of skin and soft tissue infections. Seaton RA. J Antimicrob Chemother; 2008 Nov 01; 62 Suppl 3():iii15-23. PubMed ID: 18829721 [Abstract] [Full Text] [Related]
8. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. Teng CS, Lo WT, Wang SR, Tseng MH, Chu ML, Wang CC. J Microbiol Immunol Infect; 2009 Aug 01; 42(4):324-8. PubMed ID: 19949756 [Abstract] [Full Text] [Related]
9. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies. Heizmann WR, Dupont H, Montravers P, Guirao X, Eckmann C, Bassetti M, García MS, Capparella MR, Simoneau D, Bodmann KF. J Antimicrob Chemother; 2013 Jul 01; 68 Suppl 2():ii45-55. PubMed ID: 23772046 [Abstract] [Full Text] [Related]
11. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE, Wells EM. Curr Med Res Opin; 2010 Mar 01; 26(3):571-88. PubMed ID: 20055750 [Abstract] [Full Text] [Related]
12. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. Stevens DL. J Infect; 2009 Sep 01; 59 Suppl 1():S32-9. PubMed ID: 19766887 [Abstract] [Full Text] [Related]
13. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R. Pediatrics; 2009 Jun 01; 123(6):e959-66. PubMed ID: 19470525 [Abstract] [Full Text] [Related]
14. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections. Turina M, Cheadle WG. Surg Infect (Larchmt); 2005 Jun 01; 6 Suppl 2():S-23-36. PubMed ID: 23577495 [Abstract] [Full Text] [Related]
15. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD. J Indian Med Assoc; 2009 Jan 01; 107(1):21-2, 24-5. PubMed ID: 19588683 [Abstract] [Full Text] [Related]
16. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR, Hoffman-Roberts H, Cooper T. HIV Med; 2006 Sep 01; 7(6):361-8. PubMed ID: 16903980 [Abstract] [Full Text] [Related]
17. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Marcinak JF, Frank AL. Expert Rev Anti Infect Ther; 2006 Feb 01; 4(1):91-100. PubMed ID: 16441212 [Abstract] [Full Text] [Related]
18. New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Nathwani D. Int J Antimicrob Agents; 2009 Jul 01; 34 Suppl 1():S24-9. PubMed ID: 19560672 [Abstract] [Full Text] [Related]
19. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Fritsche TR, Sader HS, Jones RN. Diagn Microbiol Infect Dis; 2007 May 01; 58(1):19-26. PubMed ID: 17383139 [Abstract] [Full Text] [Related]
20. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? Fraise AP. J Infect; 2006 Nov 01; 53(5):293-300. PubMed ID: 16876253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]